Tevogen Signs LOI to Explore HRK Healthcare Acquisition, Eyes $100M Revenue
TVGN sits 66% above its 52-week low of $3.636 on elevated volume (2.3× avg).
Summary
Tevogen signed a non-binding letter of intent to evaluate acquiring HRK Healthcare, a move that could add healthcare infrastructure and management services. Lead investor Manmohan Patel said the deal could help Tevogen reach $100 million in combined annual revenue. The company is also considering other life sciences and healthcare transactions. This follows a period of heavy insider share grants and Nasdaq compliance recoveries, but the LOI is early-stage and non-binding.
At the time of this announcement, TVGN was trading at $6.05 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $39.4M. The 52-week trading range was $3.64 to $39.00. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.